WallStreetZenWallStreetZen

NASDAQ: COEP
Coeptis Therapeutics Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their COEP stock forecasts and price targets.

Forecast return on equity

Is COEP forecast to generate an efficient return?

Forecast return on assets

Is COEP forecast to generate an efficient return on assets?
Company
-160.83%
Industry
9.42%
COEP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

COEP earnings per share forecast

What is COEP's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.26
Avg 2 year Forecast
-$0.17

COEP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
COEP$0.18N/AN/A
PULM$1.93N/AN/A
CDIO$0.30$2.00+571.14%Buy
BNOX$0.59$8.00+1,262.86%Buy
MTEM$1.12N/AN/A
View Top Biotech Stocks

Coeptis Therapeutics Holdings Stock Forecast FAQ

What is COEP's earnings growth forecast for 2024-2025?

(NASDAQ: COEP) Coeptis Therapeutics Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.77%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 29.48%.

Coeptis Therapeutics Holdings's earnings in 2024 is -$16,142,816.On average, 1 Wall Street analyst forecast COEP's earnings for 2024 to be -$10,326,834, with the lowest COEP earnings forecast at -$10,326,834, and the highest COEP earnings forecast at -$10,326,834.

In 2025, COEP is forecast to generate -$6,752,161 in earnings, with the lowest earnings forecast at -$6,752,161 and the highest earnings forecast at -$6,752,161.

If you're new to stock investing, here's how to buy Coeptis Therapeutics Holdings stock.

What is COEP's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: COEP) forecast ROE is N/A, which is considered weak.

What is COEP's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: COEP) Coeptis Therapeutics Holdings's current Earnings Per Share (EPS) is -$0.47. On average, analysts forecast that COEP's EPS will be -$0.26 for 2024, with the lowest EPS forecast at -$0.26, and the highest EPS forecast at -$0.26. In 2025, COEP's EPS is forecast to hit -$0.17 (min: -$0.17, max: -$0.17).

What is COEP's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: COEP) forecast ROA is -160.83%, which is lower than the forecast US Biotechnology industry average of 9.42%.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.